Conference Coverage

Dr. Lisa Christopher-Stine: Polymyositis? It’s more likely something else


 

EXPERT ANALYSIS FROM THE WINTER RHEUMATOLOGY SYMPOSIUM

Muscular dystrophy

Some cases of myositis mimic certain types of muscular dystrophy, Dr. Christopher-Stine said, providing a checklist of muscular dystrophies that can look “clinically completely indistinguishable from a typical inflammatory myopathy,” and should therefore be considered in these patients.

The checklist includes Duchenne’s manifesting carrier, limb girdle muscular dystrophy type 2b, myotonic dystrophy (usually type 2), and facioscapulohumeral muscular dystrophy.

Dr. Christopher-Stine reported having intellectual property interest in a novel Inova Diagnostics autoantibody assay detection for anti-HMGCR. She was also the safety officer for the JBT-101 Trial sponsored by Corbus and funded by the National Institutes of Health.

Pages

Recommended Reading

Adjuvant-boosted shingles vaccine earns FDA panel’s unanimous nod
MDedge Neurology
In close vote, advisory panel prefers Shingrix over Zostavax
MDedge Neurology
FDA: Gadolinium retention prompts new GBCA class warning, safety measures
MDedge Neurology
FDA: Gadolinium retention prompts new GBCA class warning, safety measures
MDedge Neurology
Novel herpes zoster vaccine is more cost effective than old vaccine
MDedge Neurology
MDedge Daily News: Which nonopioids are ripe for abuse?
MDedge Neurology
MDedge Daily News: Lupus is quietly killing young women
MDedge Neurology
Idiopathic inflammatory myopathies: Muscle biopsy no longer needed?
MDedge Neurology
Pregnancy registries are a valuable resource
MDedge Neurology
FDA urged to bring rheumatologists into gadolinium safety discussion
MDedge Neurology